Accession | ARO:3001314 |
Definition | Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections. |
Drug Class | pleuromutilin antibiotic |
Classification | 2 ontology terms | Show |
Parent Term(s) | 1 ontology terms | Show + pleuromutilin antibiotic [Drug Class] |
Sub-Term(s) | 10 ontology terms | Show + salA confers_resistance_to_antibiotic + salB confers_resistance_to_antibiotic + salC confers_resistance_to_antibiotic + salD confers_resistance_to_antibiotic + salE confers_resistance_to_antibiotic + vga(E) Staphylococcus cohnii confers_resistance_to_antibiotic + vmlR confers_resistance_to_antibiotic + Clostridium perfringes cplR confers_resistance_to_antibiotic + Clostridium sporogenes cplR confers_resistance_to_antibiotic + Neobacillus vireti vmlR2 confers_resistance_to_antibiotic |
Publications | Yan K, et al. 2006. Antimicrob Agents Chemother 50(11): 3875-3881. Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes. (PMID 16940066) Jones RN, et al. 2006. Antimicrob Agents Chemother 50(7): 2583-2586. Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci. (PMID 16801451) Rittenhouse S, et al. 2006. Antimicrob Agents Chemother 50(11): 3882-3885. Selection of retapamulin, a novel pleuromutilin for topical use. (PMID 17065625) Davidovich C, et al. 2007. Proc Natl Acad Sci U S A 104(11): 4291-4296. Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity. (PMID 17360517) |